Avantor Inc
NYSE:AVTR
Avantor Inc
Cash Equivalents
Avantor Inc
Cash Equivalents Peer Comparison
Competitive Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Avantor Inc
NYSE:AVTR
|
Cash Equivalents
$234.9m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
N/A
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Cash Equivalents
$5.5B
|
CAGR 3-Years
-1%
|
CAGR 5-Years
38%
|
CAGR 10-Years
14%
|
|
Danaher Corp
NYSE:DHR
|
Cash Equivalents
$7B
|
CAGR 3-Years
4%
|
CAGR 5-Years
12%
|
CAGR 10-Years
8%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Cash Equivalents
$70.2m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
Agilent Technologies Inc
NYSE:A
|
Cash Equivalents
$1.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-6%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Cash Equivalents
$1.4B
|
CAGR 3-Years
-14%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
See Also
What is Avantor Inc's Cash Equivalents?
Cash Equivalents
234.9m
USD
Based on the financial report for Mar 31, 2024, Avantor Inc's Cash Equivalents amounts to 234.9m USD.
What is Avantor Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 5Y
10%
Over the last year, the Cash Equivalents growth was -20%. The average annual Cash Equivalents growth rates for Avantor Inc have been 11% over the past three years , 10% over the past five years .